Orion Oyj (OTCMKTS:ORINF) Sees Large Growth in Short Interest

Orion Oyj (OTCMKTS:ORINF) was the target of a large increase in short interest in September. As of September 30th, there was short interest totalling 412,700 shares, an increase of 26.4% from the September 15th total of 326,500 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is presently 4,127.0 days.

Orion Oyj Price Performance

Shares of ORINF opened at $47.16 on Tuesday. The firm’s 50 day moving average price is $47.16 and its two-hundred day moving average price is $47.16. Orion Oyj has a twelve month low of $47.16 and a twelve month high of $47.16.

Orion Oyj Company Profile

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson’s disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer.